Effect of mineralocorticoid agonists and antagonists on binding of  3 H-aldosterone to adrenalectomized rat kidney plasma membranes.
D000315:Adrenalectomy; D000450:Aldosterone / Q000378:metabolism*; D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D002462:Cell Membrane / Q000378:metabolism*; D003900:Desoxycorticosterone / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D005438:Fludrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D007668:Kidney / Q000378:metabolism*; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids / Q000494:pharmacology*; D011374:Progesterone / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects; D013148:Spironolactone / Q000494:pharmacology*; D013347:Subcellular Fractions / Q000378:metabolism; D013739:Testosterone / Q000494:pharmacology; D014316:Tritium
D000451:Mineralocorticoid Receptor Antagonists; D008901:Mineralocorticoids; D011956:Receptors, Cell Surface; D014316:Tritium; D013148:Spironolactone; D013739:Testosterone; D003900:Desoxycorticosterone; D000450:Aldosterone; D011374:Progesterone; D004958:Estradiol; D005438:Fludrocortisone